Generic Medicine Info
Indications and Dosage
Nausea and vomiting, Prokinetic agent
Adult: As malate: 500 mcg tid.
Child: As malate: 15-20 mcg/kg tid.

Nausea and vomiting, Prokinetic agent
Adult: For acute symptoms: As malate: IV/IM: 0.5-1 mg.
Should be taken on an empty stomach. Take 30 min before meals.
GI haemorrhage, obstruction, perforation or immediately after surgery. Patients with pheochromocytoma.
Special Precautions
Impaired renal function, epilepsy, Parkinson's disease; history of depression. May impair ability to drive or operate machinery. Children, young patients, elderly.
Adverse Reactions
Extrapyramidal symptoms; restlessness, drowsiness, diarrhoea; hypotension, hypertension, dizziness, headache, depression; galactorrhoea.
Potentially Fatal: Neuroleptic malignant syndrome.
Drug Interactions
Other centrally active drugs and those with extrapyramidal effects. Increased toxicity with lithium. Antagonism of GI effects with antimuscarinics and opioid analgesics. May affect absorption of other drugs.
Lab Interference
Transient increased in plasma-aldosterone concentration.
Description: Clebopride is a substituted benzamide with prokinetic and antiemetic properties.
MIMS Class
GIT Regulators, Antiflatulents & Anti-Inflammatories
Disclaimer: This information is independently developed by MIMS based on Clebopride from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in